Biofarma Holding A/S: Financial statements 2022
CVR: 42243795
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Biofarma Holding A/S (CVR 42243795) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK -515,000. Equity in the 2022 report amounted to DKK 77,552,000. The solvency ratio was 99.1%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -515,000
- Equity
- DKK 77,552,000
- Total Assets
- DKK 78,292,000
- Employees
- 0
Official annual report
Keep an eye on Biofarma Holding A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Biofarma Holding A/S has published its interim report for the period March 23, 2021 – December 31, 2021.
About Biofarma Holding A/S
Biofarma Holding A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Søren Wang Petersen. The board consists of Tyge Jesper Rothe (chair), Niels Christian Assens and Søren Wang Petersen. The company is owned by CAND.PHARM. POVL M. ASSENS FOND. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 10,281,000 compared with DKK 9,891,485 the year before. Equity in the 2025 report amounted to DKK 103,544,000.